The cytotoxicity effect of bismuth oxide particles synthesized hydrothermally using different reaction temperatures in vitro

• Published in: Medical Journal of Malaysia
• Main Author: Md. Saad W.M.; Mohd Nor N.A.; Mohamad Salin N.S.; Mohd Z.; Eshak Z.; Abdul Razak H.R.
• Format: Article
• Language: English
• Published: Malaysian Medical Association 2024
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189599641&partnerID=40&md5=5d19207585e611f36c21c5fc7f9aee54

Introduction: Bismuth oxide (Bi2O3) particles gained attention in preclinical research especially in medical imaging. Bismuth oxide with its long circulation time is an alternative to the current iodine contrast media which directly possesses high X-ray attenuation coefficient. Exploration of bismuth compound is hampered owing to challenges in synthesizing control for in vivo stability. Materials and Methods: This study aimed are to characterize Bi2O3 particles synthesized at 60, 90 and 120 °C via hydrothermal method and investigated cytotoxicity of cell viability assay, cell morphology analysis, intracellular reactive oxygen species (ROS) assay and expression of ER stress genes by real-time PCR. Results: Results indicated that the size of rod-shaped Bi2O3 particles increased with rising synthesizing temperatures. The cytotoxicity of Bi2O3 particles in Chang liver cells was size-dependent. Bigger-sized Bi2O3 particles resulted in lesser toxicity effects. mRNA expressions of GRP78 and C/EBP homologous protein (CHOP) were down-regulated in all treated Chang liver cells due to the increasing size of Bi2O3 particles. Bi2O3 particles synthesized at 120 °C was found to be less toxic than iodine. Conclusion: Data suggested that the response of Chang liver cells to Bi2O3 particle cytotoxicity has a significant relationship with its reaction temperatures. This outcome is important in hazard assessment of Bi2O3 particles as a new contrast media and provides better understanding in synthesizing control to enhance its biocompatibility. © 2024, Malaysian Medical Association. All rights reserved.